Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same?

Mario Casales Schorr, José Luiz Pedrini, Ricardo Francalacci Savaris, Cláudio Galleano Zettler

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

It has been reported that pure ductal carcinoma in situ of the breast has morphologic differences from the in situ component of the invasive ductal carcinoma, as well estrogen and progesterone receptors expression according to their cytokeratin expression. However, there is no data comparing other tumor markers without using the cytokeratin expression. The objective of this study is to compare the expression of estrogen receptor (ER) and progesterone receptor (PR), HER-2/neu, p53, and Ki67 between pure ductal in situ carcinoma (pDCIS) and the in situ component of the invasive ductal carcinoma (DCIS+IDC) of the breast, and the in situ component to the invasive component of the same tumor (DCIS+IDC). The immunohistochemistry expression of the tumor markers was performed in 45 cases of pDCIS and DCIS+IDC, yielding a total of 90 cases. Statistical analysis was carried out using Fisher exact test, having a P

Original languageEnglish
Pages (from-to)51-54
Number of pages4
JournalApplied Immunohistochemistry and Molecular Morphology
Volume18
Issue number1
DOIs
Publication statusPublished - Jan 2010

Fingerprint

Carcinoma, Intraductal, Noninfiltrating
Carcinoma
Ductal Carcinoma
Progesterone Receptors
Tumor Biomarkers
Keratins
Estrogen Receptors
Breast
Carcinoma in Situ
Immunohistochemistry
Breast Carcinoma In Situ
Neoplasms

Keywords

  • Breast cancer
  • Estrogen receptor
  • HER-2/neu
  • P53
  • Progesterone receptor

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology
  • Histology

Cite this

Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same? / Schorr, Mario Casales; Pedrini, José Luiz; Savaris, Ricardo Francalacci; Zettler, Cláudio Galleano.

In: Applied Immunohistochemistry and Molecular Morphology, Vol. 18, No. 1, 01.2010, p. 51-54.

Research output: Contribution to journalArticle

Schorr, Mario Casales ; Pedrini, José Luiz ; Savaris, Ricardo Francalacci ; Zettler, Cláudio Galleano. / Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same?. In: Applied Immunohistochemistry and Molecular Morphology. 2010 ; Vol. 18, No. 1. pp. 51-54.
@article{b6dfa654bb524929bc809b0d07901dc9,
title = "Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same?",
abstract = "It has been reported that pure ductal carcinoma in situ of the breast has morphologic differences from the in situ component of the invasive ductal carcinoma, as well estrogen and progesterone receptors expression according to their cytokeratin expression. However, there is no data comparing other tumor markers without using the cytokeratin expression. The objective of this study is to compare the expression of estrogen receptor (ER) and progesterone receptor (PR), HER-2/neu, p53, and Ki67 between pure ductal in situ carcinoma (pDCIS) and the in situ component of the invasive ductal carcinoma (DCIS+IDC) of the breast, and the in situ component to the invasive component of the same tumor (DCIS+IDC). The immunohistochemistry expression of the tumor markers was performed in 45 cases of pDCIS and DCIS+IDC, yielding a total of 90 cases. Statistical analysis was carried out using Fisher exact test, having a P",
keywords = "Breast cancer, Estrogen receptor, HER-2/neu, P53, Progesterone receptor",
author = "Schorr, {Mario Casales} and Pedrini, {Jos{\'e} Luiz} and Savaris, {Ricardo Francalacci} and Zettler, {Cl{\'a}udio Galleano}",
year = "2010",
month = "1",
doi = "10.1097/PAI.0b013e3181acaded",
language = "English",
volume = "18",
pages = "51--54",
journal = "Applied Immunohistochemistry and Molecular Morphology",
issn = "1541-2016",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Are the pure in situ breast ductal carcinomas and those associated with invasive carcinoma the same?

AU - Schorr, Mario Casales

AU - Pedrini, José Luiz

AU - Savaris, Ricardo Francalacci

AU - Zettler, Cláudio Galleano

PY - 2010/1

Y1 - 2010/1

N2 - It has been reported that pure ductal carcinoma in situ of the breast has morphologic differences from the in situ component of the invasive ductal carcinoma, as well estrogen and progesterone receptors expression according to their cytokeratin expression. However, there is no data comparing other tumor markers without using the cytokeratin expression. The objective of this study is to compare the expression of estrogen receptor (ER) and progesterone receptor (PR), HER-2/neu, p53, and Ki67 between pure ductal in situ carcinoma (pDCIS) and the in situ component of the invasive ductal carcinoma (DCIS+IDC) of the breast, and the in situ component to the invasive component of the same tumor (DCIS+IDC). The immunohistochemistry expression of the tumor markers was performed in 45 cases of pDCIS and DCIS+IDC, yielding a total of 90 cases. Statistical analysis was carried out using Fisher exact test, having a P

AB - It has been reported that pure ductal carcinoma in situ of the breast has morphologic differences from the in situ component of the invasive ductal carcinoma, as well estrogen and progesterone receptors expression according to their cytokeratin expression. However, there is no data comparing other tumor markers without using the cytokeratin expression. The objective of this study is to compare the expression of estrogen receptor (ER) and progesterone receptor (PR), HER-2/neu, p53, and Ki67 between pure ductal in situ carcinoma (pDCIS) and the in situ component of the invasive ductal carcinoma (DCIS+IDC) of the breast, and the in situ component to the invasive component of the same tumor (DCIS+IDC). The immunohistochemistry expression of the tumor markers was performed in 45 cases of pDCIS and DCIS+IDC, yielding a total of 90 cases. Statistical analysis was carried out using Fisher exact test, having a P

KW - Breast cancer

KW - Estrogen receptor

KW - HER-2/neu

KW - P53

KW - Progesterone receptor

UR - http://www.scopus.com/inward/record.url?scp=76149103555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=76149103555&partnerID=8YFLogxK

U2 - 10.1097/PAI.0b013e3181acaded

DO - 10.1097/PAI.0b013e3181acaded

M3 - Article

C2 - 19568168

AN - SCOPUS:76149103555

VL - 18

SP - 51

EP - 54

JO - Applied Immunohistochemistry and Molecular Morphology

JF - Applied Immunohistochemistry and Molecular Morphology

SN - 1541-2016

IS - 1

ER -